Results from MANDARA- #EGPA pts treated with benralizumab or mepolizumab Eosinophil-targeting biologics rapidly control
Tweet Content
Results from MANDARA- #EGPA pts treated with benralizumab or mepolizumab
Eosinophil-targeting biologics rapidly control airway- & non-airway-related manifestations
Few pts had worsening of disease that progressed to organ damage over 52W
Ab0828 #ACR24 @RheumNow https://t.co/hIn9iyNVWQ
Show on Archive Page
On
Display in Search Results
On
PDQ
Off